Global Targeted Drugs for Multiple Sclerosis Market Growth (Status and Outlook) 2026-2032

February 2026 | 85 pages | ID: G18918726D00EN
LP Information

Abstracts

The global Targeted Drugs for Multiple Sclerosis market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Targeted Drugs for Multiple Sclerosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Targeted Drugs for Multiple Sclerosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Targeted Drugs for Multiple Sclerosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Targeted Drugs for Multiple Sclerosis players cover Biogen, NOVARTIS, Bristol-Myers Squibb, Janssen, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Targeted Drugs for Multiple Sclerosis Industry Forecast” looks at past sales and reviews total world Targeted Drugs for Multiple Sclerosis sales in 2025, providing a comprehensive analysis by region and market sector of projected Targeted Drugs for Multiple Sclerosis sales for 2026 through 2032. With Targeted Drugs for Multiple Sclerosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Drugs for Multiple Sclerosis industry.

This Insight Report provides a comprehensive analysis of the global Targeted Drugs for Multiple Sclerosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Drugs for Multiple Sclerosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Drugs for Multiple Sclerosis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Drugs for Multiple Sclerosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Drugs for Multiple Sclerosis.

This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Drugs for Multiple Sclerosis market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Injection
• Oral

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Biogen
• NOVARTIS
• Bristol-Myers Squibb
• Janssen
• Sanofi
• Roche

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Targeted Drugs for Multiple Sclerosis Market Size (2021-2032)
  2.1.2 Targeted Drugs for Multiple Sclerosis Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Targeted Drugs for Multiple Sclerosis by Country/Region (2021, 2025 & 2032)
2.2 Targeted Drugs for Multiple Sclerosis Segment by Type
  2.2.1 Injection
  2.2.2 Oral
  2.2.3 Targeted Drugs for Multiple Sclerosis Market Size by Type
    2.2.3.1 Targeted Drugs for Multiple Sclerosis Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Targeted Drugs for Multiple Sclerosis Market Size Market Share by Type (2021-2026)
2.3 Targeted Drugs for Multiple Sclerosis Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Other
  2.3.4 Targeted Drugs for Multiple Sclerosis Market Size by Application
    2.3.4.1 Targeted Drugs for Multiple Sclerosis Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Targeted Drugs for Multiple Sclerosis Market Size Market Share by Application (2021-2026)

3 TARGETED DRUGS FOR MULTIPLE SCLEROSIS MARKET SIZE BY PLAYER

3.1 Targeted Drugs for Multiple Sclerosis Market Size Market Share by Player
  3.1.1 Global Targeted Drugs for Multiple Sclerosis Revenue by Player (2021-2026)
  3.1.2 Global Targeted Drugs for Multiple Sclerosis Revenue Market Share by Player (2021-2026)
3.2 Global Targeted Drugs for Multiple Sclerosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 TARGETED DRUGS FOR MULTIPLE SCLEROSIS BY REGION

4.1 Targeted Drugs for Multiple Sclerosis Market Size by Region (2021-2026)
4.2 Global Targeted Drugs for Multiple Sclerosis Annual Revenue by Country/Region (2021-2026)
4.3 Americas Targeted Drugs for Multiple Sclerosis Market Size Growth (2021-2026)
4.4 APAC Targeted Drugs for Multiple Sclerosis Market Size Growth (2021-2026)
4.5 Europe Targeted Drugs for Multiple Sclerosis Market Size Growth (2021-2026)
4.6 Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Targeted Drugs for Multiple Sclerosis Market Size by Country (2021-2026)
5.2 Americas Targeted Drugs for Multiple Sclerosis Market Size by Type (2021-2026)
5.3 Americas Targeted Drugs for Multiple Sclerosis Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Targeted Drugs for Multiple Sclerosis Market Size by Region (2021-2026)
6.2 APAC Targeted Drugs for Multiple Sclerosis Market Size by Type (2021-2026)
6.3 APAC Targeted Drugs for Multiple Sclerosis Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Targeted Drugs for Multiple Sclerosis Market Size by Country (2021-2026)
7.2 Europe Targeted Drugs for Multiple Sclerosis Market Size by Type (2021-2026)
7.3 Europe Targeted Drugs for Multiple Sclerosis Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Targeted Drugs for Multiple Sclerosis by Region (2021-2026)
8.2 Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size by Type (2021-2026)
8.3 Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL TARGETED DRUGS FOR MULTIPLE SCLEROSIS MARKET FORECAST

10.1 Global Targeted Drugs for Multiple Sclerosis Forecast by Region (2027-2032)
  10.1.1 Global Targeted Drugs for Multiple Sclerosis Forecast by Region (2027-2032)
  10.1.2 Americas Targeted Drugs for Multiple Sclerosis Forecast
  10.1.3 APAC Targeted Drugs for Multiple Sclerosis Forecast
  10.1.4 Europe Targeted Drugs for Multiple Sclerosis Forecast
  10.1.5 Middle East & Africa Targeted Drugs for Multiple Sclerosis Forecast
10.2 Americas Targeted Drugs for Multiple Sclerosis Forecast by Country (2027-2032)
  10.2.1 United States Market Targeted Drugs for Multiple Sclerosis Forecast
  10.2.2 Canada Market Targeted Drugs for Multiple Sclerosis Forecast
  10.2.3 Mexico Market Targeted Drugs for Multiple Sclerosis Forecast
  10.2.4 Brazil Market Targeted Drugs for Multiple Sclerosis Forecast
10.3 APAC Targeted Drugs for Multiple Sclerosis Forecast by Region (2027-2032)
  10.3.1 China Targeted Drugs for Multiple Sclerosis Market Forecast
  10.3.2 Japan Market Targeted Drugs for Multiple Sclerosis Forecast
  10.3.3 Korea Market Targeted Drugs for Multiple Sclerosis Forecast
  10.3.4 Southeast Asia Market Targeted Drugs for Multiple Sclerosis Forecast
  10.3.5 India Market Targeted Drugs for Multiple Sclerosis Forecast
  10.3.6 Australia Market Targeted Drugs for Multiple Sclerosis Forecast
10.4 Europe Targeted Drugs for Multiple Sclerosis Forecast by Country (2027-2032)
  10.4.1 Germany Market Targeted Drugs for Multiple Sclerosis Forecast
  10.4.2 France Market Targeted Drugs for Multiple Sclerosis Forecast
  10.4.3 UK Market Targeted Drugs for Multiple Sclerosis Forecast
  10.4.4 Italy Market Targeted Drugs for Multiple Sclerosis Forecast
  10.4.5 Russia Market Targeted Drugs for Multiple Sclerosis Forecast
10.5 Middle East & Africa Targeted Drugs for Multiple Sclerosis Forecast by Region (2027-2032)
  10.5.1 Egypt Market Targeted Drugs for Multiple Sclerosis Forecast
  10.5.2 South Africa Market Targeted Drugs for Multiple Sclerosis Forecast
  10.5.3 Israel Market Targeted Drugs for Multiple Sclerosis Forecast
  10.5.4 Turkey Market Targeted Drugs for Multiple Sclerosis Forecast
10.6 Global Targeted Drugs for Multiple Sclerosis Forecast by Type (2027-2032)
10.7 Global Targeted Drugs for Multiple Sclerosis Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Targeted Drugs for Multiple Sclerosis Forecast

11 KEY PLAYERS ANALYSIS

11.1 Biogen
  11.1.1 Biogen Company Information
  11.1.2 Biogen Targeted Drugs for Multiple Sclerosis Product Offered
  11.1.3 Biogen Targeted Drugs for Multiple Sclerosis Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Biogen Main Business Overview
  11.1.5 Biogen Latest Developments
11.2 NOVARTIS
  11.2.1 NOVARTIS Company Information
  11.2.2 NOVARTIS Targeted Drugs for Multiple Sclerosis Product Offered
  11.2.3 NOVARTIS Targeted Drugs for Multiple Sclerosis Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 NOVARTIS Main Business Overview
  11.2.5 NOVARTIS Latest Developments
11.3 Bristol-Myers Squibb
  11.3.1 Bristol-Myers Squibb Company Information
  11.3.2 Bristol-Myers Squibb Targeted Drugs for Multiple Sclerosis Product Offered
  11.3.3 Bristol-Myers Squibb Targeted Drugs for Multiple Sclerosis Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Bristol-Myers Squibb Main Business Overview
  11.3.5 Bristol-Myers Squibb Latest Developments
11.4 Janssen
  11.4.1 Janssen Company Information
  11.4.2 Janssen Targeted Drugs for Multiple Sclerosis Product Offered
  11.4.3 Janssen Targeted Drugs for Multiple Sclerosis Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Janssen Main Business Overview
  11.4.5 Janssen Latest Developments
11.5 Sanofi
  11.5.1 Sanofi Company Information
  11.5.2 Sanofi Targeted Drugs for Multiple Sclerosis Product Offered
  11.5.3 Sanofi Targeted Drugs for Multiple Sclerosis Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Sanofi Main Business Overview
  11.5.5 Sanofi Latest Developments
11.6 Roche
  11.6.1 Roche Company Information
  11.6.2 Roche Targeted Drugs for Multiple Sclerosis Product Offered
  11.6.3 Roche Targeted Drugs for Multiple Sclerosis Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Roche Main Business Overview
  11.6.5 Roche Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Targeted Drugs for Multiple Sclerosis Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Targeted Drugs for Multiple Sclerosis Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. Targeted Drugs for Multiple Sclerosis Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Targeted Drugs for Multiple Sclerosis Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Targeted Drugs for Multiple Sclerosis Market Size Market Share by Type (2021-2026)
Table 8. Targeted Drugs for Multiple Sclerosis Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Targeted Drugs for Multiple Sclerosis Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Targeted Drugs for Multiple Sclerosis Market Size Market Share by Application (2021-2026)
Table 11. Global Targeted Drugs for Multiple Sclerosis Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Targeted Drugs for Multiple Sclerosis Revenue Market Share by Player (2021-2026)
Table 13. Targeted Drugs for Multiple Sclerosis Key Players Head office and Products Offered
Table 14. Targeted Drugs for Multiple Sclerosis Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Targeted Drugs for Multiple Sclerosis Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Targeted Drugs for Multiple Sclerosis Market Size Market Share by Region (2021-2026)
Table 19. Global Targeted Drugs for Multiple Sclerosis Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Targeted Drugs for Multiple Sclerosis Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Targeted Drugs for Multiple Sclerosis Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Targeted Drugs for Multiple Sclerosis Market Size Market Share by Country (2021-2026)
Table 23. Americas Targeted Drugs for Multiple Sclerosis Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Targeted Drugs for Multiple Sclerosis Market Size Market Share by Type (2021-2026)
Table 25. Americas Targeted Drugs for Multiple Sclerosis Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Targeted Drugs for Multiple Sclerosis Market Size Market Share by Application (2021-2026)
Table 27. APAC Targeted Drugs for Multiple Sclerosis Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Targeted Drugs for Multiple Sclerosis Market Size Market Share by Region (2021-2026)
Table 29. APAC Targeted Drugs for Multiple Sclerosis Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Targeted Drugs for Multiple Sclerosis Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Targeted Drugs for Multiple Sclerosis Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Targeted Drugs for Multiple Sclerosis Market Size Market Share by Country (2021-2026)
Table 33. Europe Targeted Drugs for Multiple Sclerosis Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Targeted Drugs for Multiple Sclerosis Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Targeted Drugs for Multiple Sclerosis
Table 39. Key Market Challenges & Risks of Targeted Drugs for Multiple Sclerosis
Table 40. Key Industry Trends of Targeted Drugs for Multiple Sclerosis
Table 41. Global Targeted Drugs for Multiple Sclerosis Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Targeted Drugs for Multiple Sclerosis Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Targeted Drugs for Multiple Sclerosis Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Targeted Drugs for Multiple Sclerosis Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Biogen Details, Company Type, Targeted Drugs for Multiple Sclerosis Area Served and Its Competitors
Table 46. Biogen Targeted Drugs for Multiple Sclerosis Product Offered
Table 47. Biogen Targeted Drugs for Multiple Sclerosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Biogen Main Business
Table 49. Biogen Latest Developments
Table 50. NOVARTIS Details, Company Type, Targeted Drugs for Multiple Sclerosis Area Served and Its Competitors
Table 51. NOVARTIS Targeted Drugs for Multiple Sclerosis Product Offered
Table 52. NOVARTIS Targeted Drugs for Multiple Sclerosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. NOVARTIS Main Business
Table 54. NOVARTIS Latest Developments
Table 55. Bristol-Myers Squibb Details, Company Type, Targeted Drugs for Multiple Sclerosis Area Served and Its Competitors
Table 56. Bristol-Myers Squibb Targeted Drugs for Multiple Sclerosis Product Offered
Table 57. Bristol-Myers Squibb Targeted Drugs for Multiple Sclerosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Bristol-Myers Squibb Main Business
Table 59. Bristol-Myers Squibb Latest Developments
Table 60. Janssen Details, Company Type, Targeted Drugs for Multiple Sclerosis Area Served and Its Competitors
Table 61. Janssen Targeted Drugs for Multiple Sclerosis Product Offered
Table 62. Janssen Targeted Drugs for Multiple Sclerosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Janssen Main Business
Table 64. Janssen Latest Developments
Table 65. Sanofi Details, Company Type, Targeted Drugs for Multiple Sclerosis Area Served and Its Competitors
Table 66. Sanofi Targeted Drugs for Multiple Sclerosis Product Offered
Table 67. Sanofi Targeted Drugs for Multiple Sclerosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Sanofi Main Business
Table 69. Sanofi Latest Developments
Table 70. Roche Details, Company Type, Targeted Drugs for Multiple Sclerosis Area Served and Its Competitors
Table 71. Roche Targeted Drugs for Multiple Sclerosis Product Offered
Table 72. Roche Targeted Drugs for Multiple Sclerosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Roche Main Business
Table 74. Roche Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Targeted Drugs for Multiple Sclerosis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Drugs for Multiple Sclerosis Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Targeted Drugs for Multiple Sclerosis Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Targeted Drugs for Multiple Sclerosis Sales Market Share by Country/Region (2025)
Figure 8. Targeted Drugs for Multiple Sclerosis Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Targeted Drugs for Multiple Sclerosis Market Size Market Share by Type in 2025
Figure 10. Targeted Drugs for Multiple Sclerosis in Hospital
Figure 11. Global Targeted Drugs for Multiple Sclerosis Market: Hospital (2021-2026) & ($ millions)
Figure 12. Targeted Drugs for Multiple Sclerosis in Clinic
Figure 13. Global Targeted Drugs for Multiple Sclerosis Market: Clinic (2021-2026) & ($ millions)
Figure 14. Targeted Drugs for Multiple Sclerosis in Other
Figure 15. Global Targeted Drugs for Multiple Sclerosis Market: Other (2021-2026) & ($ millions)
Figure 16. Global Targeted Drugs for Multiple Sclerosis Market Size Market Share by Application in 2025
Figure 17. Global Targeted Drugs for Multiple Sclerosis Revenue Market Share by Player in 2025
Figure 18. Global Targeted Drugs for Multiple Sclerosis Market Size Market Share by Region (2021-2026)
Figure 19. Americas Targeted Drugs for Multiple Sclerosis Market Size 2021-2026 ($ millions)
Figure 20. APAC Targeted Drugs for Multiple Sclerosis Market Size 2021-2026 ($ millions)
Figure 21. Europe Targeted Drugs for Multiple Sclerosis Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size 2021-2026 ($ millions)
Figure 23. Americas Targeted Drugs for Multiple Sclerosis Value Market Share by Country in 2025
Figure 24. United States Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Targeted Drugs for Multiple Sclerosis Market Size Market Share by Region in 2025
Figure 29. APAC Targeted Drugs for Multiple Sclerosis Market Size Market Share by Type (2021-2026)
Figure 30. APAC Targeted Drugs for Multiple Sclerosis Market Size Market Share by Application (2021-2026)
Figure 31. China Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 35. India Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Targeted Drugs for Multiple Sclerosis Market Size Market Share by Country in 2025
Figure 38. Europe Targeted Drugs for Multiple Sclerosis Market Size Market Share by Type (2021-2026)
Figure 39. Europe Targeted Drugs for Multiple Sclerosis Market Size Market Share by Application (2021-2026)
Figure 40. Germany Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 41. France Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Targeted Drugs for Multiple Sclerosis Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 54. APAC Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 55. Europe Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 57. United States Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 58. Canada Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 59. Mexico Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 60. Brazil Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 61. China Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 62. Japan Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 63. Korea Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 65. India Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 66. Australia Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 67. Germany Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 68. France Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 69. UK Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 70. Italy Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 71. Russia Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 72. Egypt Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 73. South Africa Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 74. Israel Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 75. Turkey Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)
Figure 76. Global Targeted Drugs for Multiple Sclerosis Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Targeted Drugs for Multiple Sclerosis Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Targeted Drugs for Multiple Sclerosis Market Size 2027-2032 ($ millions)